Decreased Rate of Coronary Restenosis after Lowering of Plasma Homocysteine Levels
Top Cited Papers
- 29 November 2001
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 345 (22) , 1593-1600
- https://doi.org/10.1056/nejmoa011364
Abstract
We have previously demonstrated an association between elevated total plasma homocysteine levels and restenosis after percutaneous coronary angioplasty. We designed this study to evaluate the effect of lowering plasma homocysteine levels on restenosis after coronary angioplasty.Keywords
This publication has 33 references indexed in Scilit:
- Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based populationAtherosclerosis, 1999
- Tissue Plasminogen Activator Binding to the Annexin II Tail DomainJournal of Biological Chemistry, 1998
- Homocysteine as a Risk Factor for Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Probucol and Multivitamins in the Prevention of Restenosis after Coronary AngioplastyNew England Journal of Medicine, 1997
- Catheter-Based Radiotherapy to Inhibit Restenosis after Coronary StentingNew England Journal of Medicine, 1997
- A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakesPublished by American Medical Association (AMA) ,1995
- Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Restenosis after coronary angioplasty: A multilvariate statistical model to relate lesion and procedure variables to restenosisJournal of the American College of Cardiology, 1991
- Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.Journal of Clinical Investigation, 1986
- Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.Journal of Clinical Investigation, 1986